Follow Us: Get to Know Us 23 KEPPEL BAY VIEW, REFLECTIONS AT KEPPEL BAY, Singapore (038987) 490, JUNGBONG-DAERO, SEO-GU, INCHEON, Republic of Korea (22770) 4F, UNITS B19-21, 30 YEONGJONGSUNHWAN-RO 900BEON-GIL, JUNG-GU, INCHEON, Republic of Korea [email protected]
Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients Weekly treatments of semaglutide, a GLP-1 receptor agonist from Novo Nordisk originally developed to treat diabetes, are associated with reducing a patients major adverse cardiovascular event (MACE) risk by 20%, according to initial results from the SELECT trial
The entire experience takes less than 15 minutes to complete, at which point you'll be free to return to your normal activities
You enter the fax number and recipient details, and Honest Care automatically generates a professional cover sheet